poisar

Stocks · News reference

EUDA Health Launches Regenixé iPSC-derived Skin Stem Cell Secretome Mask; Regains Nasdaq Listing Compliance

Jun 1, 2026, 10:07 AMBenzinga Newsdesk

EUDA holds the exclusive global distributorship rights for Helixé products, that includes but is not limited to, a next-generation immune health supplement, from Chemokine, a Singapore-based biotech company focused on

Read original sourceMore stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

EUDA
Source
benzinga
Observed
Jun 1, 2026, 10:07 AM
Checked
Jun 1, 2026, 10:07 AM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Aug 26, 2026, 10:00 AMEuda Health Holdings Limited

    EUDA Health Subsidiary Melana International Wins SME100 Awards 2026 Singapore

    EUDA Health Holdings Limited announced that its subsidiary Melana International Pte. Ltd. was recognized as a winner of the SME100 Awards 2026 Singapore. Melana, founded in 2000, manages 31 properties across Singapore with 5,675 residential and commercial units. The award recognizes the company's capabilities in property and strata management and adds to multiple accolades received by Melana in 2026.

    Read original at globenewswire-inc
    EUDAEUDAW